Lexaria Bioscience (LEXX) has released an update.
Lexaria Bioscience Corp. has announced a partnership with PharmaCO to test its DehydraTECH technology in pre-clinical trials, with Lexaria supplying PharmaCO with specific formulations for evaluation in animal studies. The trial, set to conclude in six months or less, could enhance how drugs are delivered into the bloodstream, potentially improving pharmaceutical efficacy.
For further insights into LEXX stock, check out TipRanks’ Stock Analysis page.
